Patrick Mooney, CEO of SpyGlass Pharma, sits down to discuss the 6-month first-in-human clinical trial data of their drug delivery platform with bimatoprost, which is implanted during routine cataract surgery.
Patrick Mooney
Advertisement
Articles by Patrick Mooney
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2025: New approaches to managing age-related eye conditions
2
AAOpt 2025: Dry eye and its neurological implications
3
AAOpt 2025: Where low-level light therapies stand as dry eye treatments and myopia management
4
Seeing the signs: The subtle clues of human trafficking as seen in the clinic
5
.png "Optometry Times"){kind=logo}
